Showing results (941-950 of 1,019) with videos related to

Sort By:
Pageof 102
Clinicoeconomics and Outcomes Research : CEOR|February 5, 2014
Cost-effectiveness of ticagrelor versus clopidogrel in patients with acute coronary syndromes in CanadaDaniel T Grima, Stephen T Brown, Laveena Kamboj, et al.
Clinicoeconomics and Outcomes Research : CEOR|April 15, 2014
Economic implications of using bendamustine, alemtuzumab, or chlorambucil as a first-line therapy for chronic lymphocytic leukemia in the US: a cost-effectiveness analysisThitima Kongnakorn, James A Sterchele, Christopher G Salvador, et al.
Clinicoeconomics and Outcomes Research : CEOR|October 21, 2016
Health and economic benefits of physical activity for patients with spinal cord injuryLarry E Miller, William G Herbert
Clinicoeconomics and Outcomes Research : CEOR|November 30, 2016
Evaluating increased resource use in fibromyalgia using electronic health recordsJay M Margolis, Elizabeth T Masters, Joseph C Cappelleri, et al.
Clinicoeconomics and Outcomes Research : CEOR|February 17, 2017
Health care resource utilization before and after natalizumab initiation among patients with multiple sclerosis in GermanyCrystal Watson, Christine Prosser, Sebastian Braun, et al.
Clinicoeconomics and Outcomes Research : CEOR|March 1, 2017
Home hemodialysis: a comprehensive review of patient-centered and economic considerationsRachael C Walker, Kirsten Howard, Rachael L Morton
Clinicoeconomics and Outcomes Research : CEOR|March 11, 2017
Optimizing choice of oral interferon-free treatment for genotype 1 hepatitis C virus using testing for NS5A resistance: a cost-utility analysis from the perspective of the Italian National Health ServiceKirsten Y Westerhout, Walter Bouwmeester, Inge Duchesne, et al.
Clinicoeconomics and Outcomes Research : CEOR|March 14, 2019
A cost-consequence analysis of parecoxib and opioids vs opioids alone for postoperative pain: Chinese perspectiveMagdolna Barra, Edit Remák, Dong Dong Liu, et al.
Clinicoeconomics and Outcomes Research : CEOR|April 3, 2019
Cost-effectiveness model for a hypothetical monotherapy vs standard of care in adult patients with treatment-resistant depressionSi-Tien Wang, Ian M Anderson, Dominic Mitchell, et al.
Clinicoeconomics and Outcomes Research : CEOR|November 23, 2018
Incremental health care resource utilization and expenditures associated with autosomal-dominant polycystic kidney diseaseNeeraj N Iyer, Nicholas J Vendetti, Daniel I Levy, et al.
Pageof 102